Sarcopenia, Cerebral Palsy, and Botulinum Toxin Type A
- PMID: 31415277
- DOI: 10.2106/JBJS.RVW.18.00153
Sarcopenia, Cerebral Palsy, and Botulinum Toxin Type A
Similar articles
-
Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.Toxins (Basel). 2010 Sep;2(9):2258-71. doi: 10.3390/toxins2092258. Epub 2010 Aug 27. Toxins (Basel). 2010. PMID: 22069684 Free PMC article. Review.
-
Botulinum toxin type A in children. New indication for limb spasticity.Prescrire Int. 2011 Mar;20(114):68. Prescrire Int. 2011. PMID: 21648226 No abstract available.
-
Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.J Orthop Sci. 2018 Mar;23(2):389-393. doi: 10.1016/j.jos.2017.10.012. Epub 2017 Nov 14. J Orthop Sci. 2018. PMID: 29146092
-
No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.Dev Med Child Neurol. 2011 Jun;53(6):553-8. doi: 10.1111/j.1469-8749.2011.03930.x. Dev Med Child Neurol. 2011. PMID: 21574991 Clinical Trial.
-
The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.J Bone Joint Surg Br. 2003 Sep;85(7):943-8. doi: 10.1302/0301-620x.85b7.13967. J Bone Joint Surg Br. 2003. PMID: 14516023 Review. No abstract available.
Cited by
-
Skeletal Muscle in Cerebral Palsy: From Belly to Myofibril.Front Neurol. 2021 Feb 18;12:620852. doi: 10.3389/fneur.2021.620852. eCollection 2021. Front Neurol. 2021. PMID: 33679586 Free PMC article. Review.
-
A nanohybrid synthesized by polymeric assembling Au(I)-peptide precursor for anti-wrinkle function.Front Bioeng Biotechnol. 2022 Dec 12;10:1087363. doi: 10.3389/fbioe.2022.1087363. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36578506 Free PMC article.
-
Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".Paediatr Drugs. 2019 Dec;21(6):497-499. doi: 10.1007/s40272-019-00359-1. Paediatr Drugs. 2019. PMID: 31583615 No abstract available.
-
Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.Toxins (Basel). 2022 Feb 14;14(2):139. doi: 10.3390/toxins14020139. Toxins (Basel). 2022. PMID: 35202166 Free PMC article.
-
Division of neuromuscular compartments and localization of the center of the highest region of muscle spindles abundance in deep cervical muscles based on Sihler's staining.Front Neuroanat. 2024 May 22;18:1340468. doi: 10.3389/fnana.2024.1340468. eCollection 2024. Front Neuroanat. 2024. PMID: 38840810 Free PMC article.
References
-
- Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016 Aug 1;17(8):675-7.
-
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. Epub 2010 Apr 13.
-
- Pagotto V, Silveira EA. Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr. 2014 Sep-Oct;59(2):288-94. Epub 2014 May 29.
-
- Deren ME, Babu J, Cohen EM, Machan J, Born CT, Hayda R. Increased mortality in elderly patients with sarcopenia and acetabular fractures. J Bone Joint Surg Am. 2017 Feb 1;99(3):200-6.
-
- Kammerlander C, Pfeufer D, Lisitano LA, Mehaffey S, Böcker W, Neuerburg C. Inability of older adult patients with hip fracture to maintain postoperative weight-bearing restrictions. J Bone Joint Surg Am. 2018 Jun 6;100(11):936-41.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical